Psychomotor effects of a new CNS stimulant, Abbott 34519.
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D006801:Humans; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D013841:Thiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced
D000928:Antidepressive Agents; D002722:Chlorobenzenes; D010919:Placebos; D011720:Pyrazoles; D013841:Thiazepines; C006299:Abbott 34519